Athena Diagnostics now offers content specific to our Canadian customers.
Please let us know where you are from.
I am from
From time to time Athena Diagnostics sends out important service related announcements including new test launches and updates via E-Mail. Please take a moment to provide an E-Mail address to which Athena may send these important announcements.
Athena Diagnostics will not sell or distribute your E-Mail address to any other company or organization. It will be used for the sole purpose of sending information on new tests and updates to existing tests. You may unsubscribe from the E-Mail list at any time. For questions regarding E-Mails you receive from Athena Diagnostics please call 800-394-4493, option 2.
You will now receive occasional updates from Athena via e-mail. Thank you!
Enter a symptom, disease type, test name or code.
Select a disorder category from the list provided.
Access forms, resources, shipping materials and educational info.
Quest Diagnostics to enhance diagnosis of pediatric neurological disorders with exclusive whole exome sequencing from Personalis
Quest Diagnostics today announced the availability of Neurome?, a whole exome sequencing service designed to aid the diagnosis of rare neurological disorders in pediatric populations. Read More >
Athena Diagnostics Launches Next-Gen Testing for Neuromuscular Diseases
Athena Diagnostics is pleased to announce the introduction of next-generation sequencing (NGS) as part of our genetic testing offering for neuromuscular diseases starting February 2nd, 2015. Read More >